Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Managing multiple autoimmune diseases in one patient is very challenging.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Aconiti Lateralis Preparata Radix helps mouse stem cells grow and turn into bone cells faster than usual methods.

The document could not be processed or understood.

The method is effective and suitable for testing finasteride tablets.

Using SNP array testing helped quickly find the gene causing Woodhouse-Sakati syndrome in two related individuals.

CS12192 effectively treats alopecia areata with better safety than current options.

The first Japanese case of a genetic hair disorder caused by specific mutations in the LIPH gene was identified.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Two specific genetic markers increase the risk of hair loss in Asian populations.

Red laser therapy helped regrow hair in an alopecia areata patient within 21 days.

The new hydrogel speeds up wound healing by reducing inflammation and promoting tissue growth.

The document's conclusion cannot be provided because the document is not readable or understandable.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

The document's conclusion cannot be summarized because the content is not accessible or understandable.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Four-amino acid part makes enzyme sensitive to finasteride.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.